Biblio

Export 924 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
M. A. Fernández-Blázquez, Ávila-Villanueva, M., Maestú, F., and Medina, M., Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment., J Alzheimers Dis, vol. 52, no. 1, pp. 271-81, 2016.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
G. J. Kinsella, Ames, D., Storey, E., Ong, B., Pike, K. E., Saling, M. M., Clare, L., Mullaly, E., and Rand, E., Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment., J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
G. J. Kinsella, Ames, D., Storey, E., Ong, B., Pike, K. E., Saling, M. M., Clare, L., Mullaly, E., and Rand, E., Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment., J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau., J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau., J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau., J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity., J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity., J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden., J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
Y. Yu, Gao, Y., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S., A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons., J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.
R. Power, Coen, R. F., Beatty, S., Mulcahy, R., Moran, R., Stack, J., Howard, A. N., and Nolan, J. M., Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial., J Alzheimers Dis, vol. 61, no. 3, pp. 947-961, 2018.
T
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
J. Lynn, Park, M., Ogunwale, C., and Acquaah-Mensah, G. K., A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
N. Pierrot, Lhommel, R., Quenon, L., Hanseeuw, B., Dricot, L., Sindic, C., Maloteaux, J. - M., Octavea, J. - N., and Ivanoiu, A., Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis., J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy., J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy., J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.

Pages